Analytical Challenges in Development of Chemoresistance Predictors for Precision Oncology
Author:
Affiliation:
1. Department of Chemistry and Centre for Research on Biomolecular Interactions, York University, Toronto M3J 1P3, Canada
2. Department of Medicine, Medical Oncology, Princess Margaret Cancer Centre, Toronto M5G 2M9, Canada
Funder
York University
Natural Sciences and Engineering Research Council of Canada
Publisher
American Chemical Society (ACS)
Subject
Analytical Chemistry
Link
https://pubs.acs.org/doi/pdf/10.1021/acs.analchem.0c02644
Reference110 articles.
1. Chemotherapy and the war on cancer
2. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy
3. Mechanisms of Drug Resistance in Cancer Chemotherapy
4. Multi-drug resistance in cancer chemotherapeutics: Mechanisms and lab approaches
5. Biphenotypic (hepatobiliary) primary liver carcinomas: the work in progress
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Automated identification and tracking of cells in Cytometry of Reaction Rate Constant (CRRC);PLOS ONE;2023-07-03
2. Advances of Artificial Intelligence in Anti-Cancer Drug Design: A Review of the Past Decade;Pharmaceuticals;2023-02-07
3. α‑hederin overcomes hypoxia‑mediated drug resistance in colorectal cancer by inhibiting the AKT/Bcl2 pathway;International Journal of Oncology;2023-01-23
4. Small Extracellular Vesicles and Their Involvement in Cancer Resistance: An Up-to-Date Review;Cells;2022-09-17
5. Sequential Measurements of Catalytic Activities of Multi-Drug-Resistance Transporters and Cytochrome P450 Enzymes by Cytometry of Reaction Rate Constant;2020-10-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3